Literature DB >> 31699788

Genetic variation of platelet glycoprotein VI and the risk of venous thromboembolism.

Hanne Skille1, Benedikte Paulsen1, Kristian Hveem2,3, Maiken E. Gabrielsen2,3, Ben Brumpton2,4,5, Kristian Hindberg1, Olga V. Gran1, Frits R. Rosendaal1,6, Sigrid K. Brækkan1,7, John-Bjarne Hansen1,7.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31699788      PMCID： PMC7327637          DOI： 10.3324/haematol.2019.231225

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  16 in total

1.  The low-frequency allele of the platelet collagen signaling receptor glycoprotein VI is associated with reduced functional responses and expression.

Authors:  Lotta Joutsi-Korhonen; Peter A Smethurst; Angela Rankin; Elaine Gray; Martin IJsseldijk; Catherine M Onley; Nicholas A Watkins; Lorna M Williamson; Alison H Goodall; Philip G de Groot; Richard W Farndale; Willem H Ouwehand
Journal:  Blood       Date:  2003-01-30       Impact factor: 22.113

2.  Joint effects of cancer and variants in the factor 5 gene on the risk of venous thromboembolism.

Authors:  Olga V Gran; Erin N Smith; Sigrid K Brækkan; Hilde Jensvoll; Terry Solomon; Kristian Hindberg; Tom Wilsgaard; Frits R Rosendaal; Kelly A Frazer; John-Bjarne Hansen
Journal:  Haematologica       Date:  2016-06-16       Impact factor: 9.941

3.  New gene variants associated with venous thrombosis: a replication study in White and Black Americans.

Authors:  H Austin; C De Staercke; C Lally; I D Bezemer; F R Rosendaal; W C Hooper
Journal:  J Thromb Haemost       Date:  2011-03       Impact factor: 5.824

Review 4.  Genetics of Venous Thrombosis: update in 2015.

Authors:  Pierre-Emmanuel Morange; Pierre Suchon; David-Alexandre Trégouët
Journal:  Thromb Haemost       Date:  2015-09-10       Impact factor: 5.249

5.  Malignancies, prothrombotic mutations, and the risk of venous thrombosis.

Authors:  Jeanet W Blom; Carine J M Doggen; Susanne Osanto; Frits R Rosendaal
Journal:  JAMA       Date:  2005-02-09       Impact factor: 56.272

6.  Family history of myocardial infarction is an independent risk factor for venous thromboembolism: the Tromsø study.

Authors:  S K Braekkan; E B Mathiesen; I Njølstad; T Wilsgaard; J Størmer; J B Hansen
Journal:  J Thromb Haemost       Date:  2008-07-26       Impact factor: 5.824

7.  Major genetic susceptibility for venous thromboembolism in men: a study of Danish twins.

Authors:  Torben Bjerregaard Larsen; Henrik Toft Sørensen; Axel Skytthe; Søren Paaske Johnsen; James W Vaupel; Kaare Christensen
Journal:  Epidemiology       Date:  2003-05       Impact factor: 4.822

8.  Evaluation of mean platelet volume as a predictive marker for cancer-associated venous thromboembolism during chemotherapy.

Authors:  Patrizia Ferroni; Fiorella Guadagni; Silvia Riondino; Ilaria Portarena; Sabrina Mariotti; Francesca La Farina; Giovanni Davì; Mario Roselli
Journal:  Haematologica       Date:  2014-08-01       Impact factor: 9.941

9.  Incidence and mortality of venous thrombosis: a population-based study.

Authors:  I A Naess; S C Christiansen; P Romundstad; S C Cannegieter; F R Rosendaal; J Hammerstrøm
Journal:  J Thromb Haemost       Date:  2007-04       Impact factor: 5.824

10.  Cohort profile: the Tromso Study.

Authors:  Bjarne K Jacobsen; Anne Elise Eggen; Ellisiv B Mathiesen; Tom Wilsgaard; Inger Njølstad
Journal:  Int J Epidemiol       Date:  2011-03-21       Impact factor: 7.196
View more
  1 in total

1.  Post-Injury Platelet Aggregation and Venous Thromboembolism.

Authors:  Zachary A Matthay; Zane J Hellmann; Brenda Nunez-Garcia; Alexander T Fields; Joseph Cuschieri; Matthew D Neal; Jeffrey S Berger; Elliot Luttrell-Williams; M Margaret Knudson; Mitchell J Cohen; Rachael A Callcut; Lucy Z Kornblith
Journal:  J Trauma Acute Care Surg       Date:  2022-04-21       Impact factor: 3.697
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.